LFWD Nasdaq Orthopedic, Prosthetic & Surgical Appliances & Supplies Financials FY2016βFY2025
Lifeward Ltd. had $22.0M of revenue in fiscal 2025, down 14.1% on the year before. Over five years, revenue changed +38.1% a year on average.
Last close Β· Oct 23, 2026
$6.06
4.2%Hi! I read Lifeward Ltd.βs latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Are sales growing?
β14.1%
No. Sales fell 14.1% last year.
Does it make a profit?
β90.4%
No. It lost money last year.
Does profit turn into cash?
β76.4%
No. It spent more cash than it brought in.
How healthy are the accounts?
4 / 8
Mixed. It passes 4 of 8 health tests.
How is the share priced?
β
No P/E: it made no profit over the last four quarters.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
In plain words: Every quarter, companies publish how much they sold and earned. These are the days Lifeward Ltd. did it, and the next one. Share prices often move a lot on those days.
Next results
November 13, 2026
Friday Β· in 18 days
| Date | Results for | Time | Source |
|---|---|---|---|
| Aug 10, 2026 | Q2 '26 | Time not announced | 8-K β |
| May 15, 2026 | Q1 '26 | Before the market opens | 8-K β |
| Mar 18, 2026 | Q4 '25 | Before the market opens | 8-K β |
| Oct 16, 2025 | Q3 '25 | Before the market opens | 8-K β |
| Aug 14, 2025 | Q2 '25 | Before the market opens | 8-K β |
| Apr 8, 2025 | Q1 '25 | Time not announced | 8-K β |
| Feb 18, 2025 | Q4 '24 | Time not announced | 8-K β |
| Nov 12, 2024 | Q3 '24 | Before the market opens | 8-K β |
From SEC filings: the results press release (8-K) or, without one, the quarterly or annual report.
KIRA Β· Lifeward Ltd. had $22.0M of revenue in fiscal 2025, down 14.1% on the year before. Over five years, revenue changed +38.1% a year on average. Its operating margin was β89.3%, up 25.1Β pts: of every 100 in sales, about β89 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
Revenue
Margins, % of revenue
Margins, % of revenue
KIRA Β· Lifeward Ltd. lost $19.9M in fiscal 2025.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
Net income
Diluted EPS
Diluted EPS
How much cash comes in, and where does it go?
KIRA Β· Free cash flow was β$16.8M in fiscal 2025, β76.4% of revenue.
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations vs capital spending
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
Diluted shares outstanding (annual)
KIRA Β· No open-market insider trades in the last 12 months.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Can it carry its debts, and how well does it use its money?
Cash, debt and the ratios that show how comfortably Lifeward Ltd. can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $88.3M | $67.9M | $28.1M | $6.7M | $2.2M |
| Current ratio | 22.9x | 15.2x | 3.3x | 2.1x | 1.3x |
| Quick ratio | 22.2x | 14.6x | 2.8x | 1.4x | 0.8x |
| Total assets | $94.8M | $74.2M | $63.2M | $30.5M | $22.9M |
| Total liabilities | $5.4M | $6.1M | $16.7M | $11.6M | $14.5M |
| Shareholders' equity | $89.4M | $68.2M | $46.5M | $18.8M | $8.4M |
| Net debt (β = net cash) | β | β | β | β | β |
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
KIRA Β· Lifeward Ltd. passes 4 of 8 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 9 | 5 / 9 | 4 / 9 | 3 / 8 | 3 / 8 | 3 / 8 | 3 / 8 | 2 / 8 | 4 / 8 |
| Accruals ratio | β18.1% | β8.3% | β36.5% | β3.7% | β1.5% | β2.1% | β2.0% | β2.1% | β15.4% | β11.6% |
| Altman Z'' | β13.50 | β21.75 | β38.35 | β22.64 | β15.51 | 16.03 | 6.66 | β8.91 | β30.70 | β44.62 |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $5.9M | $7.8M | $6.5M | $4.9M | $4.4M | $6.0M | $5.5M | $13.9M | $25.7M | $22.0M |
| Net interest income | β | β | β | β | β | $0.0M | $0.0M | $1.4M | $0.6M | β$0.3M |
| Gross profit | $0.7M | $3.1M | $2.8M | $2.7M | $2.2M | $2.9M | $1.9M | $4.5M | $8.2M | $8.4M |
| Research and development | $9.0M | $6.0M | $7.3M | $5.3M | $3.5M | $2.9M | $4.0M | $4.1M | $4.6M | $3.2M |
| Operating income | β$30.4M | β$22.0M | β$19.2M | β$14.0M | β$12.0M | β$12.7M | β$19.1M | β$23.6M | β$29.3M | β$19.7M |
| Interest expense | $2.0M | $2.5M | β | $1.5M | $0.9M | $0.0M | β | β | β | β |
| Pretax income | β$32.5M | β$24.6M | β$21.7M | β$15.5M | β$12.9M | β$12.6M | β$19.1M | β$22.1M | β$28.9M | β$20.0M |
| Income tax | $0.0M | $0.1M | β$0.0M | $0.0M | $0.1M | $0.1M | $0.5M | β$0.0M | $0.0M | β$0.1M |
| Net income | β$32.5M | β$24.7M | β$21.7M | β$15.6M | β$13.0M | β$12.7M | β$19.6M | β$22.1M | β$28.9M | β$19.9M |
| Net income to common | β$32.5M | β$24.7M | β$21.7M | β$15.6M | β$13.0M | β$12.7M | β$19.6M | β | β | β |
| Diluted EPS | β$2.47 | β$30.57 | β$14.72 | β$2.70 | β$0.82 | β$0.27 | β$2.20 | β$31.13 | β$39.96 | β$17.16 |
| Diluted shares | 0.01B | 0.00B | 0.00B | 0.01B | 0.02B | 0.05B | 0.01B | 0.00B | 0.00B | 0.00B |
| Cash flow | ||||||||||
| Cash from operations | β$26.7M | β$22.5M | β$14.8M | β$14.8M | β$12.6M | β$11.5M | β$17.9M | β$20.7M | β$21.7M | β$16.8M |
| Capital expenditure | $0.5M | $0.0M | $0.0M | $0.0M | $0.1M | $0.0M | $0.0M | $0.1M | $0.0M | $0.0M |
| Free cash flow | β$27.2M | β$22.5M | β$14.8M | β$14.8M | β$12.7M | β$11.5M | β$17.9M | β$20.7M | β$21.7M | β$16.8M |
| Depreciation and amortization | $0.7M | $0.6M | $0.5M | $0.3M | $0.3M | $0.3M | $0.2M | $0.2M | $0.5M | $0.3M |
| Stock-based compensation | $3.4M | $3.7M | $2.8M | $1.1M | $0.7M | $0.8M | $1.0M | $1.3M | $1.3M | $0.7M |
| Acquisitions | β | β | β | β | β | $0.0M | $0.0M | $18.1M | $0.0M | $0.0M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $23.7M | $14.6M | $9.5M | $16.3M | $20.4M | $88.3M | $67.9M | $28.1M | $6.7M | $2.2M |
| Total debt | $18.0M | $15.4M | $8.7M | $7.0M | β | β | β | β | β | β |
| Current assets | $29.3M | $20.9M | $13.2M | $21.1M | $25.2M | $92.5M | $72.5M | $39.2M | $21.3M | $15.8M |
| Current liabilities | $12.4M | $9.7M | $5.4M | $10.2M | $4.7M | $4.0M | $4.8M | $11.8M | $10.2M | $12.0M |
| Inventory | $3.3M | $3.6M | $2.2M | $3.1M | $3.5M | $3.0M | $2.9M | $5.7M | $6.7M | $5.7M |
| Property and equipment, net | $1.3M | $0.8M | $0.6M | $0.5M | $0.4M | $0.3M | $0.2M | $1.3M | $0.9M | $0.6M |
| Goodwill | β | β | β | β | β | β | $0.0M | $7.5M | $7.5M | $4.8M |
| Intangible assets | β | β | β | β | β | β | β | $12.5M | $0.0M | β |
| Total assets | $31.8M | $22.9M | $15.0M | $24.4M | $28.1M | $94.8M | $74.2M | $63.2M | $30.5M | $22.9M |
| Total liabilities | $23.5M | $19.2M | $13.0M | $13.6M | $6.3M | $5.4M | $6.1M | $16.7M | $11.6M | $14.5M |
| Shareholders' equity | $8.3M | $3.7M | $1.9M | $10.8M | $21.8M | $89.4M | $68.2M | $46.5M | $18.8M | $8.4M |
| Margins | ||||||||||
| Gross margin | 12.5% | 40.0% | 43.2% | 55.9% | 49.8% | 48.7% | 34.6% | 32.1% | 32.0% | 38.3% |
| Operating margin | β518.7% | β283.7% | β293.6% | β288.3% | β273.3% | β212.1% | β346.6% | β170.4% | β114.4% | β89.3% |
| EBITDA margin | β506.8% | β275.4% | β286.5% | β281.7% | β266.8% | β207.7% | β343.0% | β168.7% | β112.4% | β87.8% |
| Net margin | β553.8% | β318.8% | β331.2% | β319.1% | β295.4% | β213.5% | β355.1% | β159.8% | β112.8% | β90.4% |
| FCF margin | β463.4% | β290.0% | β225.9% | β304.5% | β288.2% | β193.0% | β325.1% | β149.8% | β84.6% | β76.4% |
| Net interest share of revenue | β | β | β | β | β | 0.0% | 0.0% | 9.8% | 2.5% | β1.4% |
| Returns | ||||||||||
| Return on capital | β926.7% | β386.8% | β1,397.7% | β743.8% | β | β | β | β | β | β |
| Return on capital employed | β157.2% | β167.4% | β200.6% | β98.9% | β51.3% | β14.0% | β27.5% | β45.9% | β144.8% | β181.1% |
| Return on equity | β393.5% | β413.1% | β767.0% | β244.4% | β79.7% | β22.9% | β24.8% | β38.6% | β88.6% | β146.1% |
| Return on assets | β102.3% | β90.5% | β114.6% | β79.1% | β49.5% | β20.7% | β23.2% | β32.2% | β61.8% | β74.6% |
| Return on tangible equity | β393.5% | β666.8% | β1,114.4% | β144.3% | β59.6% | β14.2% | β28.7% | β83.7% | β255.9% | β545.1% |
| Growth | ||||||||||
| Revenue growth | β | 32.1% | β15.6% | β25.5% | β9.9% | 35.8% | β7.6% | 151.4% | 85.2% | β14.1% |
| Share count change | β | β93.9% | 82.1% | 291.4% | 173.5% | 204.1% | β81.4% | β92.0% | 1.9% | 60.2% |
| Financial health | ||||||||||
| Debt / equity | 2.2x | 4.1x | 4.5x | 0.6x | β | β | β | β | β | β |
| Interest coverage | β15.4x | β9.0x | β | β9.4x | β13.2x | β | β | β | β | β |
| Current ratio | 2.4x | 2.2x | 2.5x | 2.1x | 5.4x | 22.9x | 15.2x | 3.3x | 2.1x | 1.3x |
| Quick ratio | 2.1x | 1.8x | 2.0x | 1.8x | 4.7x | 22.2x | 14.6x | 2.8x | 1.4x | 0.8x |
| Capital allocation | ||||||||||
| Capex / revenue | 7.7% | 0.3% | 0.2% | 0.5% | 1.7% | 0.8% | 0.5% | 0.6% | 0.0% | 0.1% |
| Stock comp / revenue | 57.9% | 47.1% | 42.3% | 22.7% | 17.0% | 14.0% | 18.0% | 9.6% | 5.0% | 3.4% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 4.0 | 5.0 | 4.0 | 3.0 | 3.0 | 3.0 | 3.0 | 2.0 | 4.0 |
| Altman Z'' | β13.5 | β21.8 | β38.3 | β22.6 | β15.5 | 16.0 | 6.7 | β8.9 | β30.7 | β44.6 |
| Accruals ratio | β18.1% | β8.3% | β36.5% | β3.7% | β1.5% | β2.1% | β2.0% | β2.1% | β15.4% | β11.6% |
Source: SEC EDGAR XBRL filings (CIK 0001607962). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
